chemo gi problems Flashcards
risk factor of cinv: age?
less than 50yo
rf for cinv: gender
female
iv high mod low risk
high >90%
moderate > 30-90%
low 10-30%
PO mod to high risk; low to moderate risk
> 30% freq / <30%
PO aprepitant dose day 1
125 mg
ondansetron dose
8-16mg
granisetron dose
1 mg
dexa day 1 dose
12 mg od
dexa day 2 dose
8 mg od
high risk day 1 drug regimen
akynzeo + dexa
OR
aprepitant + ondansetron + dexa
olz dose
5mg (2.5mg for elderly)
moderate intensity day 1
ondansetron + dexa
low risk day 1
ondansetron or dexa or metocloperamide
day 2 high risk
8 mg OD
po aprepitant day 2/3
80 mg OD
agents for both acute and delayed therapy
nk1 antagonist
dexa
atypical antipsych
agents for only acute therapy
ondansetron / metocloperamide
bzd used for
anticipatory cv
haloperidol dose for refractory cinv
po 0.5-2mg q4-6
uncomplicated diarrhoea tx
po loperamide 4mg, then 2mg q4h or after every diarrhoea. until 12h diarrhoea free
complicated diarrhoea tx
sq octreotide 100-150 tds, can increase 50mg q24hrly
add on cipro 500mg 7d
diarrhoea age rf
above 65
diarrhoea rf ecog status
at least 2
other rf of cid
bowel malignancy/inflammation
first chemo cycle
cycle dx at least 3 weeks
concomittant neutropenia
vomiting anorexia anemia
grade 1 cid
<4 stools per day above baseline
grade 2 cid
4-6 stools per day above baseline
grade 3
at least 7 stools per day abv baseline
hospitalisation needed
octreotide moa
decreases fluid secretion and increases fluid absorption
octreotide se
bradycardia, arrhythmia, enlarged thyroid, nv
irinotecan associated diarrhoea early prevention and tx
sc atropine 0.25-1mg
irinocetan assiociate diarrhoea late tx
loperamide 4 mg then 2mg q2h until 12h diarrhoea
nk1 antagonist ddi
steroids, warfarin, bzd, ifosfamide